Evidence map›Paper›PMID 24423447›Full record

ArticleMolecular pharmacology2014

Eudistomin D and penaresin derivatives as modulators of ryanodine receptor channels and sarcoplasmic reticulum Ca2+ ATPase in striated muscle.

Paula L Diaz-Sylvester, Maura Porta, Vanessa V Juettner, Yuanzhao Lv, Sidney Fleischer, Julio A Copello

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Paula L Diaz-SylvesterDepartment of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (P.L.D.-S., V.V.J., Y.L., J.A.C.); Department of Physiology, Midwestern University, Chicago School of Osteopathic Medicine, Downers Grove, Illinois (M.P.); and Departments of Biological Sciences and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee (S.F.).
Maura Porta
Vanessa V Juettner
Yuanzhao Lv
Sidney Fleischer
Julio A Copello
Midwestern University · USSouthern Illinois University School of Medicine · US

Funding

Communication neighboring ryanodine receptor channelsR01GM078665 · NIGMS · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI COPELLO, JULIO A · 2006 to 2010
$1.3M
NIGMS NIH HHS R01 GM078665NIGMS NIH HHS R01-GM078665
6 · The paper itself

Abstract

Eudistomin D (EuD) and penaresin (Pen) derivatives are bioactive alkaloids from marine sponges found to induce Ca(2+) release from striated muscle sarcoplasmic reticulum (SR). Although these alkaloids are believed to affect ryanodine receptor (RyR) gating in a "caffeine-like" manner, no single-channel study confirmed this assumption. Here, EuD and MBED (9-methyl-7-bromoeudistomin D) were contrasted against caffeine on their ability to modulate the SR Ca(2+) loading/leak from cardiac and skeletal muscle SR microsomes as well as the function of RyRs in planar bilayers. The effects of these alkaloids on [(3)H]ryanodine binding and SR Ca(2+) ATPase (SERCA) activity were also tested. MBED (1-5 μM) fully mimicked maximal activating effects of caffeine (20 mM) on SR Ca(2+) leak. At the single-channel level, MBED mimicked the agonistic action of caffeine on cardiac RyR gating (i.e., stabilized long openings characteristic of "high-open-probability" mode). EuD was a partial agonist at the maximal doses tested. The tested Pen derivatives displayed mild to no agonism on RyRs, SR Ca(2+) leak, or [(3)H]ryanodine binding studies. Unlike caffeine, EuD and some Pen derivatives significantly inhibited SERCA at concentrations required to modulate RyRs. Instead, MBED's affinity for RyRs (EC50 ∼ 0.5 μM) was much larger than for SERCA (IC50 > 285 μM). In conclusion, MBED is a potent RyR agonist and, potentially, a better choice than caffeine for microsomal and cell studies due to its reported lack of effects on adenosine receptors and phosphodiesterases. As a high-affinity caffeine-like probe, MBED could also help identify the caffeine-binding site in RyRs.

Indexed as

AnimalsCaffeineCalciumCalcium Channel AgonistsCalcium Channel BlockersCalcium-Transporting ATPasesCarbolinesIndole AlkaloidsIn Vitro TechniquesLipid BilayersMicrosomesMuscle, SkeletalMyocardiumProtein BindingRabbitsRyanodine Receptor Calcium Release Channel9-methyl-7-bromoeudistomin DCaffeineCalciumCalcium Channel AgonistsCalcium Channel BlockersCalcium-Transporting ATPasesCarbolineseudistomin DIndole AlkaloidsLipid BilayersRyanodine Receptor Calcium Release Channel

Identifiers

PMID24423447
PMCPMC3965891
OpenAlexW2106555500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.